Patients Lacking Straight Answers on Safety of E-Cigarettes

This article originally appeared here.
Share this content:
Patients Lacking Straight Answers on Safety of E-Cigarettes
Patients Lacking Straight Answers on Safety of E-Cigarettes

FRIDAY, Aug. 26, 2016 (HealthDay News) -- Doctors disagree on the best way to answer patient questions about electronic cigarettes, according to a study published online Aug. 26 in the American Journal of Preventive Medicine.

Researchers analyzed 512 online discussions between doctors and patients about e-cigarettes. About 34 percent of patient questions were about the side effects and dangers of e-cigarettes; 27 percent were about general safety; and 19 percent about using e-cigarettes to stop smoking. Side effects and safety were also the most common topics that doctors raised.

About half of doctors' answers to patient questions were negative, focusing on e-cigarette risks and advising patients not to use them. About 20 percent of answers were positive, such as using e-cigarettes as a tool to stop smoking traditional cigarettes. Asked specifically about quitting smoking, 54 percent of doctors mentioned e-cigarettes as a possible aid.

"Examination of online patient-provider communications provides insight into consumer health experience with emerging alternative tobacco products. Patient concerns largely related to harms and safety, and patients preferred provider responses positively inclined toward e-cigarettes," the authors write. "Lacking conclusive evidence of e-cigarette safety or efficacy, health care providers encouraged smoking cessation and recommended first-line cessation treatment approaches."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »